nach oben

Diabetologia

Erschienen in:

01.07.2013 | Article

A novel mechanism regulating insulin secretion involving Herpud1 in mice

verfasst von: N. Wong, G. Morahan, M. Stathopoulos, J. Proietto, S. Andrikopoulos

Erschienen in: Diabetologia | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Type 2 diabetes results from beta cell dysfunction after prolonged physiological stress, which causes oversecretion of insulin. We recently found that insulin hypersecretion is mediated by at least two genes. Among mouse models of type 2 diabetes, the DBA/2 mouse strain is more susceptible to diabetes than is the C57BL/6J (B6J) strain. One distinctive feature of the DBA/2 mouse is that it hypersecretes insulin, independent of changes in insulin sensitivity; we identified Nnt as a gene responsible for this trait.

Methods

To identify the other gene(s) affecting insulin hypersecretion, we tested a panel of recombinant inbred BXD strains, which have different combinations of B6 and DBA/2 alleles.

Results

We found that 25% of the BXD strains hypersecreted insulin in response to glucose. Microarray profiling of islets from high- and low-secretor strains showed that at least four genes were differentially expressed. One gene was consistently underexpressed in islets from both DBA/2 and the high-secretor BXD strains. This gene (Herpud1 or Herp) encodes the 54 kDa endoplasmic reticulum stress-inducible protein (HERP) that resides in the integral endoplasmic reticulum membrane. To test directly whether Herpud1 can interact with Nnt, Herpud1 was either knocked down or overexpressed in MIN6 cells. These results showed that when Herpud1 was suppressed, Nnt expression was reduced, while overexpression of Herpud1 led to increased Nnt expression. Furthermore, Herpud1 suppression resulted in significantly decreased glucose-stimulated insulin secretion in the DBA/2 islets but not B6J islets.

Conclusions/interpretation

We conclude that Herpud1 regulates insulin secretion via control of Nnt expression.

Nur mit Berechtigung zugänglich

Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC (2002) Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 277:10912–10921PubMedCrossRef

Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437–1442PubMedCrossRef

Pratley RE, Wilson C, Bogardus C (1995) Relation of the white blood cell count to obesity and insulin resistance: effect of race and gender. Obes Res 3:563–571PubMedCrossRef

Kaku K, Fiedorek FT Jr, Province M, Permutt MA (1988) Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control. Diabetes 37:707–713PubMedCrossRef

Kirchhoff K, Machicao F, Haupt A et al (2008) Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51:597–601PubMedCrossRef

Andrikopoulos S (2010) Obesity and type 2 diabetes: slow down!—Can metabolic deceleration protect the islet beta cell from excess nutrient-induced damage? Mol Cell Endocrinol 316:140–146PubMedCrossRef

Leiter EH, Coleman DL, Hummel KP (1981) The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex. Diabetes 30:1029–1034PubMedCrossRef

Zraika S, Aston-Mourney K, Laybutt DR et al (2006) The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets. Diabetologia 49:1254–1263PubMedCrossRef

Kooptiwut S, Zraika S, Thorburn AW et al (2002) Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology 143:2085–2092PubMedCrossRef

10.

Aston-Mourney K, Wong N, Kebede M et al (2007) Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia 50:2476–2485PubMedCrossRef

11.

Viberti G, Kahn SE, Greene DA et al (2002) A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes Care 25:1737–1743PubMedCrossRef

12.

Wong N, Blair AR, Morahan G, Andrikopoulos S (2010) The deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance. Endocrinology 151:96–102PubMedCrossRef

13.

Taylor B (1989) Recombinant inbred strains. In: Lyon ML, Searle AG (eds) Genetic variants and strains of the laboratory mouse, 2nd edn. Oxford University Press, Oxford, pp 773–796

14.

BXD Genotypes Database www.genenetwork.org/dbdoc/BXDGeno.html (2003), accessed 12 March 2013

15.

Peirce JL, Lu L, Gu J, Silver LM, Williams RW (2004) A new set of BXD recombinant inbred lines from advanced intercross populations in mice. BMC Genet 5:7PubMedCrossRef

16.

Kebede M, Favaloro J, Gunton JE et al (2008) Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes 57:1887–1895PubMedCrossRef

17.

Morahan G, Williams RW (2007) Systems genetics: the next generation in genetics research? Novartis Found Symp 281:181–188, discussion 188–191, 208–189PubMedCrossRef

18.

Kokame K, Agarwala KL, Kato H, Miyata T (2000) Herp, a new ubiquitin-like membrane protein induced by endoplasmic reticulum stress. J Biol Chem 275:32846–32853PubMedCrossRef

19.

Goksel DL, Fischbach K, Duggirala R et al (1998) Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia. Hum Genet 103:280–285PubMedCrossRef

20.

Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE (2000) A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49:2094–2101PubMedCrossRef

21.

Glaser B, Kesavan P, Heyman M et al (1998) Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226–230PubMedCrossRef

22.

Kim TY, Kim E, Yoon SK, Yoon JB (2008) Herp enhances ER-associated protein degradation by recruiting ubiquilins. Biochem Biophys Res Commun 369:741–746PubMedCrossRef

23.

Kny M, Standera S, Hartmann-Petersen R, Kloetzel PM, Seeger M (2011) Herp regulates Hrd1-mediated ubiquitylation in a ubiquitin-like domain-dependent manner. J Biol Chem 286:5151–5156PubMedCrossRef

24.

Okuda-Shimizu Y, Hendershot LM (2007) Characterization of an ERAD pathway for nonglycosylated BiP substrates, which require Herp. Mol Cell 28:544–554PubMedCrossRef

25.

Carvalho P, Goder V, Rapoport TA (2006) Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 126:361–373PubMedCrossRef

26.

Sai X, Kawamura Y, Kokame K et al (2002) Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J Biol Chem 277:12915–12920PubMedCrossRef

27.

Chtarbova S, Nimmrich I, Erdmann S et al (2002) Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activation. Biochem J 367:723–728PubMedCrossRef

28.

Chan SL, Fu W, Zhang P et al (2004) Herp stabilizes neuronal Ca2+ homeostasis and mitochondrial function during endoplasmic reticulum stress. J Biol Chem 279:28733–28743PubMedCrossRef

29.

Hirabayashi Y, Oka Y, Ikeda T et al (2010) The endoplasmic reticulum stress-inducible protein, Herp, is a potential triggering antigen for anti-DNA response. J Immunol 184:3276–3283PubMedCrossRef

30.

Eura Y, Yanamoto H, Arai Y, Okuda T, Miyata T, Kokame K (2012) Derlin-1 deficiency is embryonic lethal, Derlin-3 deficiency appears normal, and Herp deficiency is intolerant to glucose load and ischemia in mice. PLoS One 7:e34298PubMedCrossRef

31.

Mekada K, Abe K, Murakami A et al (2009) Genetic differences among C57BL/6 substrains. Exp Anim 58:141–149PubMedCrossRef

32.

Bock T, Pakkenberg B, Buschard K (2005) Genetic background determines the size and structure of the endocrine pancreas. Diabetes 54:133–137PubMedCrossRef

33.

Davis RC, van Nas A, Castellani LW et al (2012) Systems genetics of susceptibility to obesity-induced diabetes in mice. Physiol Genom 44:1–13CrossRef

34.

An P, Freedman BI, Rich SS et al (2006) Quantitative trait loci on chromosome 8q24 for pancreatic beta-cell function and 7q11 for insulin sensitivity in obese nondiabetic white and black families: evidence from genome-wide linkage scans in the NHLBI Hypertension Genetic Epidemiology Network (HyperGEN) study. Diabetes 55:551–558PubMedCrossRef

35.

Suto J, Sekikawa K (2002) A quantitative trait locus that accounts for glucose intolerance maps to chromosome 8 in hereditary obese KK-A(y) mice. Int J Obes Relat Metab Disord 26:1517–1519PubMedCrossRef

Titel: A novel mechanism regulating insulin secretion involving Herpud1 in mice
verfasst von: N. Wong
G. Morahan
M. Stathopoulos
J. Proietto
S. Andrikopoulos
Publikationsdatum: 01.07.2013
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 7/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-013-2908-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2013

Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2 β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brain

Effects of immunosuppression on alpha and beta cell renewal in transplanted mouse islets

Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry

Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative

Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice